| Titolo |
Pubblicato in |
Anno |
| IFN-α neutralizing antibodies distinguish LADA from early-onset type 1 diabetes |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2025 |
| Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study |
DIABETES, OBESITY AND METABOLISM |
2024 |
| No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study |
CLINICAL THERAPEUTICS |
2024 |
| Sex Differences in Cardiovascular Disease and Cardiovascular Risk Estimation in Patients With Type 1 Diabetes |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2023 |
| Short-term effectiveness of dapagliflozin versus {DPP}-4 inhibitors in elderly patients with type 2 diabetes: a multicentre retrospective study |
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION |
2023 |
| Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications |
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES |
2023 |
| Hepatic steatosis with significant fibrosis is associated with an increased 10-year estimated risk of cardiovascular disease in adults with type 1 diabetes mellitus |
CARDIOVASCULAR DIABETOLOGY |
2023 |
| Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus |
DIABETES & METABOLISM |
2023 |
| MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus |
DIABETES & METABOLISM |
2023 |
| Development of a clinical risk score to predict death in patients with COVID-19 |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2022 |
| Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease |
THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM |
2022 |
| Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study: The CoVaDiab study I |
DIABETES/METABOLISM RESEARCH AND REVIEWS |
2022 |
| Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study |
DIABETES RESEARCH AND CLINICAL PRACTICE |
2021 |
| Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study |
DIABETES, OBESITY AND METABOLISM |
2021 |
| Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes |
DIABETES RESEARCH AND CLINICAL PRACTICE |
2021 |
| Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis |
INTERNAL AND EMERGENCY MEDICINE |
2021 |
| Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes |
EXPERT OPINION ON INVESTIGATIONAL DRUGS |
2021 |
| Adult-onset autoimmune diabetes in 2020: An update |
MATURITAS |
2020 |
| Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) |
DIABETES RESEARCH AND CLINICAL PRACTICE |
2020 |
| Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) |
CARDIOVASCULAR DIABETOLOGY |
2020 |
